Biocomposites Takes Minority Stake in Renovos Biologics
July 5, 2023
Biocomposites has taken a minority equity stake in Renovos Biologics to support development and pre-market approval of the RENOVITE nanoclay therapeutic delivery platform. The investment will give Renovos access to Biocomposites' development expertise and global distribution network; Biocomposites CEO Michael Harris will join Renovos' board.
- Buyers
- Biocomposites
- Targets
- Renovos Biologics
- Industry
- Biotechnology
- Location
- Hampshire, United Kingdom
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.